3 employees
Amakem is a kinase platform company developing therapeutics for the treatment of serious eye conditions.
2010
$25M
from 3 investors over 3 rounds
Amakem NV raised $25M on September 6, 2011
Investors: Forbion, Vesalius Biocapital and Omnes